Systemic lupus erythematosus therapeutic strategy: From immunotherapy to gut microbiota modulation
2024

New Treatments for Systemic Lupus Erythematosus

publication Evidence: moderate

Author Information

Author(s): Chasov Vitaly, Zmievskaya Ekaterina, Ganeeva Irina, Gilyazova Elvina, Davletshin Damir, Filimonova Maria, Valiullina Aygul, Kudriaeva Anna, Bulatov Emil

Primary Institution: Institute of Fundamental Medicine and Biology, Kazan Federal University

Hypothesis

Can gut microbiota modulation and advanced immunotherapies improve treatment outcomes for systemic lupus erythematosus?

Conclusion

Emerging therapies, including CAR-T cell therapy and gut microbiota modulation, show promise in treating systemic lupus erythematosus.

Supporting Evidence

  • Immunotherapies targeting B and T cells have shown encouraging results in clinical trials.
  • Chimeric antigen receptor T cell therapy is emerging as a promising treatment option for systemic lupus erythematosus.
  • Normalization of gut microbiota through fecal microbiota transplantation may provide new treatment opportunities.

Takeaway

Doctors are finding new ways to help people with lupus by using special treatments that target the immune system and by fixing the bacteria in our tummies.

Methodology

The review discusses advances in immunotherapies and the role of gut microbiota in systemic lupus erythematosus.

Limitations

The review does not provide specific clinical trial data or detailed statistical analyses.

Digital Object Identifier (DOI)

10.7555/JBR.38.20240009

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication